Manufacturer record
Alco Formulation (India): regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Alco Formulation (India) (Haryana) were declared Not of Standard Quality between June 2022 and August 2022. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: PRT - 938, Paracetamol Tablets IP 650 mg. (DOL-P*650) (exp Apr 2023). RDTL Guwahati (state lab) found it not of standard quality: Dissolution. Listed in the August 2022 alert.
Records by type
2 records linked to Alco Formulation (India) in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Paracetamol Tablets IP 650 mg. (DOL-P*650) | Batch PRT - 938Mfg May 2021 · Exp Apr 2023 | DissolutionDissolution | RDTL GuwahatiState lab | Aug 2022 |
| Paracetamol Tablets IP 650mg. | Batch PRT-938Mfg May 2021 · Exp Apr 2023 | DissolutionDissolution | RDTL GuwahatiState lab | Jun 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.